Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-063225

Director bought 315 shares at an average $2.72 ($857)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2021-10-01 Purchase +15 $2.69 $40 13,688 D
Young Caroline Director 2021-10-04 Purchase +15 $2.87 $43 13,703 D
Young Caroline Director 2021-10-05 Purchase +15 $2.82 $42 13,718 D
Young Caroline Director 2021-10-06 Purchase +15 $2.76 $41 13,733 D
Young Caroline Director 2021-10-07 Purchase +15 $2.76 $41 13,748 D
Young Caroline Director 2021-10-08 Purchase +15 $2.84 $43 13,763 D
Young Caroline Director 2021-10-11 Purchase +15 $2.73 $41 13,778 D
Young Caroline Director 2021-10-12 Purchase +15 $2.71 $41 13,793 D
Young Caroline Director 2021-10-13 Purchase +15 $2.71 $41 13,808 D
Young Caroline Director 2021-10-14 Purchase +15 $2.81 $42 13,823 D
Young Caroline Director 2021-10-15 Purchase +15 $2.76 $41 13,838 D
Young Caroline Director 2021-10-18 Purchase +15 $2.75 $41 13,853 D
Young Caroline Director 2021-10-19 Purchase +15 $2.76 $41 13,868 D
Young Caroline Director 2021-10-20 Purchase +15 $2.63 $39 13,883 D
Young Caroline Director 2021-10-21 Purchase +15 $2.65 $40 13,898 D
Young Caroline Director 2021-10-22 Purchase +15 $2.66 $40 13,913 D
Young Caroline Director 2021-10-25 Purchase +15 $2.64 $40 13,928 D
Young Caroline Director 2021-10-26 Purchase +15 $2.64 $40 13,943 D
Young Caroline Director 2021-10-27 Purchase +15 $2.61 $39 13,958 D
Young Caroline Director 2021-10-28 Purchase +15 $2.61 $39 13,975 D
Young Caroline Director 2021-10-29 Purchase +15 $2.72 $41 13,988 D
Open-market purchases · 315 sh · avg $2.72 · $857
Loading xslF345X03/doc4.xml…